88 related articles for article (PubMed ID: 7717931)
1. Once daily dosing of aminoglycosides.
Matthews Z; Cistulli K; Barnes D
Aust N Z J Med; 1994 Dec; 24(6):730; author reply 731. PubMed ID: 7717931
[No Abstract] [Full Text] [Related]
2. Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Douchain F; Lebas L; Houdas S; Chivet C; Bakhache P; Pautard JC
Acta Univ Carol Med (Praha); 1990; 36(1-4):37-9. PubMed ID: 2130714
[No Abstract] [Full Text] [Related]
3. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
[TBL] [Abstract][Full Text] [Related]
4. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis.
Hoekstra MO; van Aalderen WM
Thorax; 1997 Apr; 52(4):398-9. PubMed ID: 9196534
[No Abstract] [Full Text] [Related]
5. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
Kerrebijn KF; Mouton J
Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
[No Abstract] [Full Text] [Related]
7. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
[TBL] [Abstract][Full Text] [Related]
8. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
Madsen V; Lind A; Rasmussen M; Coulthard K
J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
[TBL] [Abstract][Full Text] [Related]
11. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
Hubert D; Desmazes-Dufeu N; Dusser D
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).
Bergogne-Berezin E
Infection; 1987; 15(4):288-94. PubMed ID: 3312023
[No Abstract] [Full Text] [Related]
13. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
[TBL] [Abstract][Full Text] [Related]
14. Once-daily versus multiple-daily dosing of aminoglycosides.
Craig WA
J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
[TBL] [Abstract][Full Text] [Related]
15. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
16. [Evaluation of three dosage regimens of amikacin using pharmacokinetic models in patients with cystic fibrosis].
Halacová M; Průsa R; Kotaska K; Vávrová V
Cas Lek Cesk; 2004; 143(3):187-90. PubMed ID: 15134039
[TBL] [Abstract][Full Text] [Related]
17. Inhaled aminoglycosides in cystic fibrosis.
Jew LL; Hart LL
DICP; 1990; 24(7-8):711-2. PubMed ID: 2197811
[No Abstract] [Full Text] [Related]
18. Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis.
Guggenbichler JP; Allerberger F; Dierich MP; Schmitzberger R; Semenitz E
Lancet; 1988 Sep; 2(8613):749-50. PubMed ID: 2901603
[No Abstract] [Full Text] [Related]
19. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].
Sermet-Gaudelus I; Ferroni A; Vrielinck S; Lebourgeois M; Chedevergne F; Lenoir G
Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394
[TBL] [Abstract][Full Text] [Related]
20. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
Kernen Y; Sauty A; Roulet M
Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
